Brainsway Ltd.

General Information
Business:

(Note: Not an IPO, a Public Offering: “Our ordinary shares are listed on the Tel Aviv Stock Exchange, or the TASE, under the symbol “BRIN.” On April 2, 2019, the last reported sale price of our ordinary shares on the TASE was NIS 21.64, or $5.97 per share (based on the exchange rate reported by the Bank of Israel on such date, which was NIS 3.624 = US$1.00). In this prospectus, we have assumed an initial public offering price of $11.94 per ADS, based on the last reported sale price of our ordinary shares on the TASE on April 2, 2019.”

We are a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using our proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which we have received marketing authorization from the U.S. Food and Drug Administration (FDA). Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. Our technology can either increase brain activity in neuronal networks which are hypoactive, or alternatively decrease brain activity in neuronal networks which are hyperactive. Our proprietary electromagnetic coils, which we refer to as H-Coils, are designed to safely stimulate deep and broad brain regions, which we believe provides an advantage over other available TMS products, which we refer to collectively as Focal TMS, that generally use a “figure 8” design. We believe that our Deep TMS technology has the potential to be safe and effective for the treatment of a wide range of psychiatric, neurological and addiction disorders beyond MDD and OCD.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 96
Founded: 2006
Contact Information
Address 19 Hartum Street, Bynet Building, 3rd Floor, Har HaHotzvim, Jerusalem 91451, Israel
Phone Number +972-2-581-3140
Web Address http://www.brainsway.com
View Prospectus: Brainsway Ltd.
Financial Information
Market Cap $238.0mil
Revenues $16.4 mil (last 12 months)
Net Income $6.5 mil (last 12 months)
IPO Profile
Symbol BWAY
Exchange NASDAQ
Shares (millions): 2.5
Price range $11.00 - $11.00
Est. $ Volume $27.5 mil
Manager / Joint Managers Cantor/ Raymond James/ Oppenheimer
CO-Managers Ladenburg Thalmann
Expected To Trade:
Status:
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change